Skip to main content

Table 4 Effect of PE on anti-cancer treatment

From: Prognosis of incidental pulmonary embolism vs. symptomatic pulmonary embolism in cancer patients: a single-center retrospective cohort study in China

 

IPE, N = 88

SPE, N = 92

P-value

Affected

38 (43.2)

42 (45.6)

0.640

 Delayed

16 (18.2)

4 (4.7)

0.003*

 Dosage decreased

1 (1.1)

1 (1.1)

0.740

 Stopped

13 (14.8)

25 (27.2)

0.042*

 Changed

9 (10.2)

12 (13.0)

0.556

  1. Data are presented as n (%)
  2. IPE, incidental pulmonary embolism; SPE, symptomatic pulmonary embolism; PE, pulmonary embolism; * means P < 0.05
Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us